J7612Levalbuterol non-comp con
Published CMS Medicare Part B payment-limit context for J7612, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.
CMS payment limit
$0.343
per 0.5 MG · Medicare Part B
Up 7.5%from $0.319 in 2026-Q2
- Current quarter
- Billing unit
Payment limit over time
$0.4051$0.2119
2024-Q4: $0.233; 2025-Q1: $0.294; 2025-Q2: $0.283; 2025-Q3: $0.30; 2025-Q4: $0.274; 2026-Q1: $0.384; 2026-Q2: $0.319; 2026-Q3: $0.343
No current FDA shortage matchThe latest completed FDA data has no affected record matching the Levalbuterol Hydrochloride ingredient family (FDA data as of August 20, 2026).
Levalbuterol Inhalation Solution Concentrated
Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.
Other Levalbuterol Hydrochloride presentations
1 other CMS codeSource-linked same ingredient-family context, not recommendations, substitutes, or clinical or billing equivalence.
Swipe to see all columns
| HCPCS | CMS description | Current quarter 2026-Q3 | Prior quarter 2026-Q2 | Change | NDCs | View history |
|---|---|---|---|---|---|---|
| J7614 | Levalbuterol non-comp unit | $0.075 per 0.5 MG | $0.086 per 0.5 MG | Down 12.8% |
Put another code on your radar.
Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.